We believe that no other biomedical discipline has greater implications for human health than immunology. By unraveling the complexities of the immune system, LJI researchers are directly tackling an extraordinarily diverse array of diseases, such as asthma, cancer, CoVID-19, type 1 diabetes, Parkinson’s, and many others.
At La Jolla Institute for Immunology, every day, our discoveries move the world closer to Life Without Disease.
La Jolla Institute is home to three research centers that focus the efforts of collaborative groups of researchers on defined areas of inquiry, to accelerate progress toward the development of new treatments and vaccines to prevent and cure autoimmune conditions, cancer and infectious disease.
Research into different autoimmune diseases can inform the development of new treatments that teach the immune system to tolerate the body’s own cells.
The Center is at the forefront of exploring new and sometimes unexpected avenues for novel immune-based cancer treatments.
Amid the COVID-19 pandemic, LJI infectious disease experts quickly mobilized a task force to respond to the current crisis.
To speed inoculations, the U.S. plans to release all available vaccine doses and open access to anyone over 65. Others suggest straying from recommended doses or intentionally delaying boosters. The best way forward remains uncertain.
Once immunity is widespread in adults, the virus rampaging across the world will come to resemble the common cold, scientists predict.
New findings suggest that immune response to COVID-19 may be long-lasting.
Speaker: Christine Bender, Ph.D.
La Jolla Institute for Immunology
Host: Matthias Von Herrath, Ph.D.
Link: Webinar Link
Speaker: Lai Wen, Ph.D.
La Jolla Institute for Immunology
Host: Klaus Ley, Ph.D.
Link: Webinar Link